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Introduction
Exopolysaccharides (EPS) are extracellular biopolymers
that are produced by many lactic acid bacteria (LAB) and
other bacteria present in fermented foods and human
environments, such as propionibacteria and bifidobacteria
(Ruas-Madiedo et al. 2009b). In fact, the EPS-producing
strains are used in the dairy industry because of the abil-
ity of their polymers to act as biological stabilizers, visco-
sifiers, emulsifiers and gelling agents (Abraham et al.
2009; Behare et al. 2009). In addition, in recent years,
several health benefits have been attributed to EPS from
LAB (Ruas-Madiedo et al. 2008).
The ecological role of EPS for the producing bacteria is
not completely understood. It has been reported that they
could be involved in cell recognition, adhesion to surfaces
and biofilm formation, which would enhance the coloni-
zation of different ecosystems (Ruas-Madiedo et al. 2008).
In this regard, it has been proposed that EPS produced
by intestinal lactobacilli and bifidobacteria could be
involved in the adherence to intestinal mucus and also in
the interaction with enteropathogens (Ruas-Madiedo
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Abstract
Aims: To evaluate the capability of the exopolysaccharides (EPS) produced by
lactobacilli and bifidobacteria from human and dairy origin to antagonize the
cytotoxic effect of bacterial toxins.
Methods and Results: The cytotoxicity of Bacillus cereus extracellular factors on
Caco-2 colonocytes in the presence ⁄ absence of the EPS was determined by
measuring the integrity of the tissue monolayer and the damage to the cell
membrane (extracellular lactate dehydrogenase activity). Additionally, the
protective effect of EPS against the haemolytic activity of the streptolysin-O
was evaluated on rabbit erythrocytes. The EPS produced by Bifidobacterium
animalis ssp. lactis A1 and IPLA-R1, Bifidobacterium longum NB667 and Lacto-
bacillus rhamnosus GG were able to counteract the toxic effect of bacterial
toxins on the eukaryotic cells at 1 mg ml)1 EPS concentration. The EPS A1
was the most effective in counteracting the effect of B. cereus toxins on colono-
cytes, even at lower doses (0Æ5 mg ml)1), whereas EPS NB667 elicited the
highest haemolysis reduction on erythrocytes.
Conclusions: The production of EPS by lactobacilli and bifidobacteria could
antagonize the toxicity of bacterial pathogens, this effect being EPS and biologi-
cal marker dependent.
Significance and Impact of the Study: This work allows gaining insight about
the mechanisms that probiotics could exert to improve the host health.
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et al. 2006). Also, EPS produced by bifidobacteria are able
to modulate the intestinal microbiota by acting as fer-
mentable substrates (Salazar et al. 2008, 2009b). On the
other hand, bacterial EPS could counteract the activity of
bacteriophages (Durlu-O¨zkaya et al. 2007) and of toxic
compounds (Looijesteijn et al. 2001; Kim et al. 2006).
The synthesis of EPS in the gut ecosystem could confer
a selective advantage for the survival and colonization of
this niche by the producing bacteria. Indeed, EPS could
improve the survival throughout the gastrointestinal tract
of orally delivered bacteria given that bile is able to
induce the synthesis of these polymers in Bifidobacterium
animalis (Ruas-Madiedo et al. 2009a). In the gut environ-
ment, it has also been reported that kefiran, the EPS pro-
duced by LAB in the fermented milk kefir, is able to
antagonize the biological activity of Bacillus cereus and also
their extracellular factors on Caco-2 colonocytes (Medrano
et al. 2008, 2009). However, there is no evidence as to
whether EPS produced by lactobacilli and bifidobacteria
from intestinal origin are able to exert similar protective
effects against the activity of bacterial toxins.
The aim of this work was to evaluate the effect of the
EPS produced by the strains Lactobacillus rhamnosus GG,
Bifidobacterium longum NB667, Bifidobacterium animalis
ssp. lactis A1 and IPLA-R1 on the biological activity trig-
gered by bacterial toxins (extracellular factors of B. cereus
and streptolysin-O (SLO) from Streptococcus pyogenes) on
different eukaryotic cell models (Caco-2 cells and rabbit
erythrocytes).
Materials and methods
Bacterial strains and culture conditions
The bacterial strains used in this study are shown in
Table 1. Stock cultures of B. cereus B10502 were stored at
)80°C in BHI (Brain Heart Infusion; Biokar Diagnostics,
Beauvais, France) using glycerol 1% (v ⁄ v) as cryo-protec-
tive agent. The strain was re-activated in BHI supple-
mented with glucose 0Æ1% (w ⁄ v) for 16 h at 32°C in an
orbital shaker, and these cultures were used to inoculate
(4% v ⁄ v) 5 ml of fresh BHI-glucose that was incubated
under the same conditions. Cell-free supernatants were
obtained after centrifugation (900 g, 10 min) and filtra-
tion (0Æ45 lm). Serial dilutions of supernatants were
made in phosphate-buffered saline (PBS: KH2PO4
0Æ144 g l)1, Na2HPO4 0Æ795 g l
)1 and NaCl 9 g l)1).
The four EPS-producing lactobacilli and bifidobacteria
strains (Table 1) were maintained at )80°C in MRSC
broth [MRS (Biokar) + 0Æ25% (w ⁄ v) l-cysteine (Sigma
Chemical Co., St. Louis, MO, USA)] with 20% glycerol.
For the isolation of EPS, frozen stocks were grown over-
night at 37°C under anaerobic atmosphere (10% H2, 10%
CO2, and 80% N2) in a Mac500 chamber (Down Whitley
Scientific, West Yorkshire, UK). Cultures (200 ll) were
used to inoculate agar-MRSC plates using sterile glass
beads. Plates were incubated for 5 days at 37°C in
anaerobic conditions.
Isolation and characterization of the EPS
For the isolation of the EPS, cell biomass was collected
from agar-MRSC plates using 2 ml ultrapure water per
plate and the resulting volume was mixed with one
volume of 2 mol l)1 NaOH. The suspension was gently
stirred overnight at room temperature to promote polymer
release, and afterwards cells were removed by centrifuga-
tion (8400 g, 30 min). The EPS fraction was precipitated
using two volumes of cold-absolute ethanol (4°C, 48 h),
followed by centrifugation, resuspension in ultrapure
water and dialysis for 3 days at 4°C with a daily change
of water using dialysis tubes (Sigma) of 12–14 kDa
molecular mass cut off. Finally, the dialysed EPS were
freeze-dried (Ruas-Madiedo et al. 2006).
The protein content of the EPS fractions was deter-
mined by the BCA protein assay kit (Pierce, Rockford, IL,
USA). The molar mass (MM) and radius of gyration (Rg)
of the EPS were measured by size-exclusion chromatogra-
phy and multi-angle laser light scattering detection
(SEC-MALLS, Salazar et al. 2009b). The monosaccharide
composition was determined by GC–MS (Salazar et al.
2009a). The phosphate content of each EPS was directly
measured in an atomic emission spectroscopy Perkin
Elmer 5500 inductively coupled plasma (Perkin Elmer,
Norwalk, CT, USA) at the ‘Centro de Ciencias Medioam-
bientales’ (CCM-CSIC, Madrid).
Table 1 Micro-organism used in this study
Species Strains Origin*
Bacillus cereus B10502 Food poisoning outbreak (Minnaard et al. 2004)
Lactobacillus rhamnosus GG (LMG18243) LMG Culture collection (human faeces)
Bifidobacterium animalis
ssp. lactis
A1
IPLA-R1
Isolated from commercial dairy product
Bile-adapted strain from A1 (IPLA collection)
Bifidobacterium longum NB667 NIZO Culture collection (infant faeces)
*LMG: Belgian Co-ordinated Collections of Micro-organisms (Gent, Belgium) and NIZO Food
Research Collection (Ede, the Netherlands).
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Each EPS was resuspended in PBS solution at
20 mg ml)1, and several dilutions ranging from 0Æ05 to
1 mg ml)1 were used for experiments.
Culture of human Caco-2 cell line
Caco-2 cells were routinely grown in Dulbecco’s modi-
fied Eagle’s medium (DMEM) containing 25 mmol l)1
glucose (GIBCO BRL Life Technologies, Rockville, MD
USA), supplemented with 15% (v ⁄ v) heat-inactivated
(30 min at 56°C) foetal calf serum (PAA Laboratories
GmbH, Pasching, Austria), 1% (v ⁄ v) nonessential amino
acids (PAA Laboratories GmbH), penicillin (12 UI
ml)1), streptomycin (12 lg ml)1), gentamicin (50 lg
ml)1) and fungizone (1Æ25 lg ml)1). For maintenance
purposes, the cell line was passed weekly, using 0Æ02%
(w ⁄ v) trypsin (Sigma) in PBS containing 3 mmol l)1
EDTA. Cell suspensions (1 · 105 cells per ml) were
seeded in 6- or 24-well plates (Greiner Bio One, Frick-
enhausen, Germany) and incubated to form confluent-
differentiated monolayers for 14 ± 1 days at 37°C in a
5% CO2 atmosphere. The culture medium was changed
every 2 days, and the experiments were performed with
cells among passages 56 and 60.
Detachment of Caco-2 cells
The integrity of the Caco-2 monolayers was determined
by measuring the cell detachment as previously reported
by Minnaard et al. (2001). Briefly, differentiated cells
grown in 24-well plates were co-incubated with several
dilutions (from 1 ⁄ 2 to 1 ⁄ 64) of B. cereus B10502 superna-
tants at 37°C in 5% CO2 atmosphere for 150 min in pres-
ence of different EPS concentrations (0, 0Æ05, 0Æ5 and
1 mg ml)1). After incubation, Caco-2 cells were washed
with PBS, fixed for 1 min with 2% (w ⁄ v) formaldehyde
in PBS and washed again. Staining was performed with
500 ll of crystal violet solution [0Æ13% crystal violet, 5%
ethanol and 2% formaldehyde (w ⁄ v ⁄ v) in PBS] by incu-
bating for 20 min. Afterwards, stain excess was washed
with PBS, and samples were treated for 1 h with 50%
(v ⁄ v) ethanol. Absorbance of stained cells was measured
at 590 nm in a Metrolab 330 spectrophotometer (Metro-
lab, Buenos Aires, Argentina). The percentage of attached
cells was calculated as the absorbance of treated cells with
respect to the absorbance of untreated-control cells (sus-
pended in PBS and incubated in the absence of B. cereus
supernatant and EPS).
Lactate dehydrogenase activity in Caco-2 cells
Caco-2 cell membrane integrity was determined by mea-
suring the extracellular lactate dehydrogenase (LDH)
activity using the LDH-P unitest kit (Weiner Lab,
Rosario, Argentina), following the manufacturer’s speci-
fications. Differentiated Caco-2 cells grown in six-well
plates were co-incubated with serial dilutions (1 ⁄ 16 to
1 ⁄ 32) of B. cereus B10502 cell-free supernatants in the
presence (1 mg ml)1) and absence of bacterial EPS at
37°C in 5% CO2 atmosphere for 2 h. The extracellular
LDH activity was determined by mixing 50 ll of Caco-2
supernatants with the enzyme substrate and incubating
at 30°C. Absorbance at 340 nm was measured
continuously during 120 s in a spectrophotometer
Beckman DU650 (Beckman, Brea, CA, USA), and LDH
activity was calculated as the decrease in absorbance for
60 s.
Haemolysis of erythrocytes
The putative protective effect of EPS against the toxic
activity of SLO from Strep. pyogenes upon erythrocytes
was assessed according to Promdonkoy and Ellar (2003).
Commercial SLO (Sigma) was diluted in PBS containing
20 mmol l)1 l-cysteine, adjusted to pH 7Æ4, filtered and
mixed with (2% v ⁄ v) rabbit erythrocytes suspended in
PBS. Toxin units used in the experiments were around
300 UI enzyme per ml [one unit is defined as the
amount of enzyme able to cause 50% lysis of 50 ll of
2% (v ⁄ v) red blood suspension in PBS, pH 7Æ4 at 37°C
in 30 min]. Erythrocyte suspensions were co-incubated
with SLO in the presence (1 mg ml)1) and absence of the
EPS at 37°C for 60 min. Two control samples were used:
0% lysis (erythrocytes in absence of SLO toxin) and
100% lysis [erythrocytes treated with 0Æ2% Triton X-100
(Sigma) in PBS]. Absorbance decrease in erythrocyte sus-
pensions was measured at 600 nm in a Metrolab 330
spectrophotometer at different sampling points for
60 min. The percentage of remaining (not lysed) erythro-
cytes in the samples was calculated as follows:
100 · (absorbance of sample ) absorbance of 100% lysis
control) ⁄ (absorbance of 0% lysis control ) absorbance of
100% lysis control).
Statistical analysis
All experiments have been carried out at least in tripli-
cate. Statistical analysis was performed using the spss-pc
11.0 software (SPSS Inc., Chicago, IL, USA). Data were
subjected to an one-way anova, and the least significant
difference test was used for the subsequent comparison
of means. For the haemolysis data and within each type
of EPS sample, a paired samples t-test was performed
to compare the percentage of remaining erythrocytes
after 60 min of incubation with respect to the initial
values.
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Results
Physico-chemical characteristics of the bacterial EPS
Table 2 shows the protein content, MM distribution and
chemical composition of the EPS analysed. The protein
content of the EPS was in general lower than 3%, indi-
cating high-carbohydrate content and thus a good degree
of purity of the polymer. Lactobacillus rhamnosus GG
synthesized a unique peak of 2Æ2 · 105 Da. However, the
EPS synthesized by Bifidobacterium strains (A1, IPLA-R1
and NB667) presented more than one peak of different
MM. The EPS produced by Bif. longum NB667 had two
polymer fractions, one of low (4Æ3 · 103 Da) MM and
another of high (4Æ4 · 106 Da) MM. Bif. animalis ssp.
lactis A1 and IPLA-R1 are closely related strains. A bile-
resistant derivative strain (A1dOx) was obtained from the
parental A1 by gradual adaptation to bile salts. This bile-
adapted strain converted spontaneously to a stable ropy
phenotype by successive subcultivation, resulting in the
strain IPLA-R1. The ropy phenotype of IPLA-R1 strain is
absent in the parental A1, and these two strains produced
polymers differing in MM and peak distribution
(Table 2). Both strains share two EPS fractions of low
MM (around 3 · 104 and 5 · 103 Da), but IPLA-R1 is
able to additionally produce, in high amounts (56%), an
EPS of high (3Æ5 · 106 Da) MM, probably being respon-
sible for the ropy character. The EPS produced by these
closely related strains also differed in their monosaccha-
ride ratio composition. The EPS fraction A1 showed a
higher glucose and galactose, and lower rhamnose, ratio
than IPLA-R1. Although EPS NB667 and GG also have
the same monomers in their composition, the ratio
among the four polymers was different. It is worth noting
that EPS A1 and IPLA-R1 also have phosphate in their
composition, which was not detected in NB667 and GG.
Finally, variations in the Rg of the highest MM peak of
each EPS were also detected with values of 13, 17, 47 and
67 nm for EPS GG, A1, IPLA-R1 and NB667, respec-
tively. These results show a high variability in the physi-
co-chemical characteristics of the bacterial EPS used in
this study, which could account for different biological
effects.
Effect of bacterial EPS against Bacillus cereus cytotoxicity
on Caco-2 cells
The protective effect of the bacterial EPS against the toxic
effect of B. cereus extracellular factors on Caco-2 cells was
determined by testing the integrity of Caco-2 cell mono-
layer. Figure 1 shows the Caco-2 cells that remained
adhered to the surface of the well plates after co-incuba-
tion with serial dilutions (1 ⁄ 16 to 1 ⁄ 64) of B. cereus
supernatants in the presence (1 mg ml)1) and absence of
EPS. Under these experimental conditions, all EPS were
able to significantly (P < 0Æ05) antagonize the cell detach-
ment triggered by B. cereus B10502 supernatants at the
highest toxin concentration (dilution 1 ⁄ 16), the EPS A1
being able to display the highest protection. At B. cereus
supernatant 1 ⁄ 32 and 1 ⁄ 64 dilutions, the lower toxin con-
centration did not induce the detachment of the Caco-2
monolayers in the control (absence of EPS) samples, and
no differences with respect to the presence of the EPS
were detected. Higher toxin concentrations (dilutions 1 ⁄ 2
to 1 ⁄ 8, data not shown) caused the total detachment of
the cells, and no protection was observed with any of the
EPS assayed. Taking into account the previous results, the
EPS with the highest (EPS A1) and one of the lowest
(IPLA-R1) antagonism capability against B. cereus super-
natant toxicity on Caco-2 cells were chosen to study a
putative dose-response effect of these EPS (Fig. 2). For
EPS A1, a significant (P < 0Æ05) protection effect was
detected at concentrations higher than 0Æ05 mg ml)1,
whereas for EPS IPLA-R1 was detected only at 1 mg ml)1.
In addition, at the highest EPS concentration tested
(1 mg ml)1), the percentage of cells that remained
adhered was significantly higher (P < 0Æ001) for EPS
A1 than for EPS IPLA-R1. Thus, the differential EPS
characteristics may have account for this variability in the
protective capability between both EPS.
Table 2 Physico-chemical characteristics of the exopolysaccharides (EPS) used in this study
EPS
Protein
(%)
Molar mass (Da) distribution (%)* Monosaccharide ratio 
Peak 1 Peak 2 Peak 3 Glc Gal Rham PO4
A1 3Æ1 ) 2Æ8 · 104 (44%) 5Æ0 · 103 (56%) 2Æ5 2 1 +
IPLA-R1 2Æ6 3Æ5 · 106 (56%) 3Æ0 · 104 (21%) 4Æ9 · 103 (23%) 1 1 1Æ5 +
NB667 2Æ2 4Æ4 · 106 (47%) ) 4Æ3 · 103 (53%) 1 2 1 )
GG 2Æ9 ) 2Æ2 · 105 (100%) ) 1 4 1 )
*Percentage calculated with respect to the total amount (lg) of peaks measured by size-exclusion chromatography (SEC-MALLS).
 Glu, glucose; Gal, galactose; Rham, rhamnose.
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To evaluate Caco-2 cell membrane integrity, the extra-
cellular release of LDH activity (a cytoplasmatic enzyme)
was measured in the milieu of Caco-2 co-cultivated with
B. cereus supernatant dilutions 1 ⁄ 16 and 1 ⁄ 32 in the pres-
ence (1 mg ml)1) and absence of bacterial EPS (Fig. 3).
The four EPS tested showed significant differences
(P < 0Æ05) with respect to the control (absence EPS) sam-
ple at both toxin concentrations tested. The effect was
also significant (P < 0Æ001) at low-toxin concentration
(dilution 1 ⁄ 32). As similarly occurred when cell detach-
ment was analysed, the EPS fraction NB667 showed the
lowest protective effect of the four EPS analysed. Thus,
this result suggests that bacterial EPS exerted a protective
effect on Caco-2 cells by avoiding the loss of membrane
integrity and ⁄or the release of cytoplasmatic content.
Effect of EPS against SLO toxin on erythrocyte cells
The results presented earlier prompted us to study the
effect of these EPS on the biological activity of large-pore
forming toxins. Rabbit erythrocytes were employed to
evaluate the putative protection of bacterial EPS against
the haemolytic activity of the commercial bacterial haem-
olysin SLO. Kinetics of haemolysis performed in the pres-
ence (1 mg ml)1) and absence of the EPS under study are
depicted in Fig. 4. The remaining erythrocytes of all sam-
ples significantly diminished with respect to the initial
values after 60 min of erythrocyte co-incubation with the
SLO toxin (paired t-test: P < 0Æ001). However, when the
EPS were added, the rate of haemolysis decreased and sig-
nificant differences were found at the end of the incuba-
tion period with respect to the sample in absence of EPS
(P < 0Æ05). It is worth noting that in the case of haemo-
lysis, the EPS A1 displayed the lowest protection capa-
bility of the four EPS tested, whereas the EPS NB667
showed the highest. This represents an opposite tendency
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Figure 1 Percentage of Caco-2 cells adhered to the well plate after treatment with several dilutions (1 ⁄ 16, 1 ⁄ 32 and 1 ⁄ 64) of Bacillus cereus
B10502 supernatants in the absence (white bars) and presence (1 mg ml)1) of the exopolysaccharides isolated from the strains Bifidobacterium
animalis ssp. lactis A1 and IPLA-R1, Bifidobacterium longum NB667 and Lactobacillus rhamnosus GG (grey bars). The percentage of cells that
remained attached was calculated as follows: 100 · [590- nm absorbance of treated samples ⁄ absorbance of control cells (incubated in absence
of B. cereus supernatant)]. Within each supernatant dilution, the columns with different letters are statistically different (P < 0Æ05) according to
the least significant difference mean comparison test.
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Figure 2 Percentage of Caco-2 cells that remained adhered to the
well plate after the treatment with the dilution 1 ⁄ 16 of Bacillus cereus
B10502 supernatant in the presence of several concentrations of the
exopolysaccharides (EPS) isolated from the strains Bifidobacterium
animalis ssp. lactis A1 and IPLA-R1. Concentrations: 0 (h), 0Æ05 ( ),
0Æ5 ( ) and 1 ( ) mg ml)1. Within each EPS, the columns that do not
have a common superscript are statistically different (P < 0Æ05) accord-
ing to the least significant difference mean comparison test. At the
highest concentration (1 mg ml)1), an one-way anova test was per-
formed to analyse differences between both polymers (***P < 0Æ001).
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with respect to that observed for the model Caco-2 and
extracellular toxins of B. cereus.
Discussion
The capability of bacterial EPS to antagonize the mem-
brane eukaryotic cell damage triggered by B. cereus extra-
cellular factors and by SLO from Strep. pyogenes, was
evaluated in two complementary cell models: colonocyte-
like cells (Caco-2 cellular line) and rabbit erythrocytes.
These bacterial toxins produce different effects upon
eukaryotic cells. B. cereus can trigger in humans diverse
symptoms related to their adhesion to the intestinal epi-
thelium and invasion of enterocytes (Minnaard et al.
2004) and ⁄or because of the production of a wide range
of extracellular factors such as cytolysins (cereolysin-O),
phospholipases and haemolysins, among others (Alouf
2000; Minnaard et al. 2007; Stenfors-Arnesen et al. 2008).
The SLO belongs to the large-pore forming family of tox-
ins (Alouf 2000; Thelestam 2000), in which is included
the cereolysin-O from B. cereus. In this study, we have
shown that the EPS produced by strains of lactobacilli
and bifidobacteria are able to counteract the toxic effect
of bacterial toxins. However, the effect was different
depending on the EPS considered and also on the biologi-
cal (eukaryotic cell) marker studied.
In the case of the B. cereus supernatants, the EPS IPLA-
R1 and NB667 showed the lowest protection capability by
preventing the Caco-2 cell de-attachment and ⁄or the
LDH release. A common feature of these two polymers is
the production of a high-MM EPS fraction (>106 Da).
The high-MM fraction is not present in the EPS synthe-
sized by strain A1 (parental strain of IPLA-R1), which
exerted the highest protection, suggesting that the high-
MM fraction is not necessary to exert the protective effect
against B. cereus toxins. Additionally, the protective effect
of EPS A1 was detected at lower doses (0Æ5 mg ml)1)
than EPS IPLA-R1, and at the concentration of
1 mg ml)1, the EPS A1 elicited a significantly higher
antagonic effect than IPLA-R1. The medium MM
(2Æ2 · 105 Da) EPS produced by GG strains had a biolog-
ical effect closer to EPS A1. However, the kefiran isolated
from the kefir grains, which is a branched glucogalactan
with an MM higher than 107 Da (Piermarı´a et al. 2008),
was able to significantly abrogate the cytotoxic effect of
LDH activity
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Figure 3 Extracellular lactate dehydrogenase (LDH) activity of Caco-2 cells after co-cultivation with Bacillus cereus B10502 supernatants (dilutions
1 ⁄ 16 and 1 ⁄ 32) in the absence (white bars) and presence (grey bars) of the exopolysaccharides (1 mg ml)1) isolated from the strains Bifidobacterium
animalis ssp. lactis A1 and IPLA-R1, Bifidobacterium longum NB667 and Lactobacillus rhamnosus GG. The LDH activity was calculated as the decrease
in absorbance at 340 nm after 60 s of reaction. Within each B. cereus supernatant dilution, the columns that have not a common superscript are
statistically different (P < 0Æ05) according to the least significant difference mean comparison test.
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Figure 4 Lysis kinetics of rabbit erythrocytes co-incubated with strep-
tolysin-O toxin (300 UI) without exopolysaccharides (EPS) (¤) or with
1 mg ml)1 of EPS A1 (h), EPS IPLA-R1 (4), EPS GG (d) and EPS
NB667 (s). The percentage of remaining erythrocytes was calculated
as follows: 100 · (600- nm absorbance of sample ) absorbance of
100% lysis control) ⁄ (absorbance of 0% lysis control ) absorbance of
100% lysis control). At the end of the reaction period (60 min), the
symbols that do not share a common letter are statistically different
(P < 0Æ05) according to the least significant difference mean compari-
son test.
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B. cereus toxins at similar concentrations (from 0Æ3 to
1 mg ml)1, Medrano et al. 2008) than our EPS A1. Thus,
the MM of a polymer is not the only determining factor
involved in its protective capability. Also the chemical
composition, type of union and the spatial structure of
the EPS could be involved in the different biological
effect. With respect to the putative mechanism against
B. cereus toxins, the bacterial EPS could act by blocking
the toxin receptors in the eukaryotic cell or by capturing
the toxin, thus avoiding its interaction with the receptor.
In both cases, the EPS would avoid the initiation of an
intracellular cascade response that ends with the death, by
necrosis or apoptosis, of the eukaryotic cell (Henderson
et al. 1999).
Regarding the antagonism of bacterial EPS against the
haemolytic activity of SLO on erythrocytes, our EPS
were able to diminish the rate of haemolysis. However,
in this case, the EPS A1 showed the lower percentage of
protection and the EPS NB667 the highest; this is just
the opposite behaviour of that detected for the Caco-
2 ⁄B. cereus toxins system. This finding suggested that
the mechanism involved in haemolysis protection might
be different to that involved in cell detachment. One of
the main mechanisms leading to haemolysis by haemo-
lysins, such as SLO (and also the cereolysin-O from
B. cereus), is the oligomerization and assembly of toxin
monomers into the cytoplasmic membrane of eukaryotic
cells, thus forming large pores (Palmer et al. 1998;
Henderson et al. 1999). The EPS produced by our bifido-
bacteria and lactobacilli might display their antagonism
by hindering the contact of the toxin with the erythro-
cyte membrane; this will avoid the toxin-subunits oligo-
merization and pore formation, thus EPS could exert
osmotic protection. In this way, MM and Rg are impor-
tant structural characteristic of EPS to be considered.
We observed that the lowest protection on haemolysis
was obtained with EPS with low MM and Rg, this is
the EPS A1.
Thus, it seems that polymers having small Rg and low
MM might be able to better abrogate the cytotoxic effect
of B. cereus toxins, but are less effective for large-pore
forming toxin such as SLO. The physical parameters and
chemical composition of EPS are related to the structure
of the repeating units that build the polymers. In our
case, with the exception of EPS GG (Landersjo¨ et al.
2002), the repeating units of EPS A1, IPLA-R1 and
NB667 are still unknown. Thus, we do not have enough
data to conclude that the MM and Rg are the unique
parameters directly related to the anti-toxin effect of our
EPS and to extend this conclusion to other bacterial EPS.
However, it is well known that the physico-chemical char-
acteristics of bacterial EPS are directly correlated with
their technological and biological functionality (Ruijssena-
ars et al. 2000; Vaningelgem et al. 2004; Mozzi et al.
2009; Salazar et al. 2009a). Therefore, it seems that the
physico-chemical properties of the EPS would also deter-
mine the specific interactions with eukaryotic cell recep-
tors and ⁄or with toxins.
Conclusions
The EPS synthesized by the human and dairy origin
strains Lact. rhamnosus GG, Bif. longum NB667, Bif. ani-
malis ssp. lactis A1, and its bile-adapted derivative
IPLA-R1, are able to exert an in vitro antagonic effect
against the cytophatic effect on Caco-2 cells triggered
by B. cereus extracellular factors and against the haemo-
lytic activity of a large-pore forming toxin, such as
SLO, on rabbit erythrocytes. Differences among EPS
depended on the biological marker studied and could
be attributed to the variability of the physico-chemical
characteristics of these biopolymers. Although the pro-
tective mechanisms are still not fully understood, it is
tempting to hypothesize that the bacterial EPS could act
by blocking receptors on the eukaryotic cell surface or
by acting as toxin-scavenger agents. Nevertheless, the
capability to abrogate the activity of bacterial toxins by
EPS produced by lactobacilli and bifidobacteria is
another mechanism involved in the antagonism against
virulence factors of bacterial pathogens exerted by pro-
biotic strains.
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